SCHEMBL30364014

SCHEMBL30364014

N#Cc1c(N)cc(Cl)c2c1CCO2

nearest known ligand 0.36

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 9/20 0.36
HTR4 Q13639 2/20 0.31
MAPK1 P28482 1/20 0.30
GAA P10253 2/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
HPGD P15428 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23363821 1.00 MAPKAPK2 (0.36) MAPKAPK2HTR4MAPK1GAAKDM4E
SCHEMBL26522281 0.81 MAPKAPK2 (0.36) MAPKAPK2GAAKDM4EALDH1A1LMNA
SCHEMBL30364099 0.81 MAPKAPK2 (0.36) MAPKAPK2GAAKDM4EALDH1A1LMNA
SCHEMBL23363903 0.75 VCAM1 (0.40) MAPK1ALDH1A1HPGD
SCHEMBL25213075 0.75 HTR2A (0.37) GAA
SCHEMBL23363798 0.75 GAA (0.33) HTR4GAA
SCHEMBL27221599 0.74 MAPKAPK2 (0.36) MAPKAPK2GAAKDM4EALDH1A1LMNA
SCHEMBL29934754 0.73 KDM4E (0.42) MAPK1GAAKDM4EALDH1A1LMNA
SCHEMBL23363867 0.73 KDM4E (0.42) MAPK1GAAKDM4EALDH1A1LMNA
SCHEMBL5035685 0.72 HTR4 (0.41) HTR4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116262759-B Pyrimidine tricyclic compound, and preparation method and medical application thereof 华润医药研究院(深圳)有限公司 2023-12-08 CN disclosed
CN-116262759-A Pyrimidine tricyclic compound, and preparation method and medical application thereof 华润医药研究院(深圳)有限公司 2023-06-16 CN disclosed
CN-116234797-A Heterocyclic inhibitors of TEAD for the treatment of cancer 基因泰克公司 2023-06-06 CN disclosed
EP-4185386-A1 HETEROCYCLIC INHIBITORS OF TEAD FOR TREATING CANCER Genentech, Inc. (US) 2023-05-31 EP disclosed